Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
January 24 2023 - 9:00AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to
release its fourth quarter and full year 2022 financial results
after market close on Thursday, February 9, 2023. Management will
hold a conference call to review the company's fourth quarter and
full year 2022 performance starting at 4:30 p.m. (Eastern Time) on
the same day. The conference call will be concurrently webcast. The
link to the webcast will be available on the Dexcom investor
relations website at investors.dexcom.com and will be archived
there for future reference.
To listen to the conference call, please dial (888) 414-4585
(US/Canada) or (646) 960-0331 (International) and use the
confirmation ID "9430114" approximately five minutes prior to the
start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of
diabetes through innovative continuous glucose monitoring (CGM)
systems. Headquartered in San Diego, California, and with
operations across Europe and select parts of Asia/Oceania, Dexcom
has emerged as a leader of diabetes care technology. By listening
to the needs of users, caregivers, and providers, Dexcom simplifies
and improves diabetes management around the world. For more
information about Dexcom CGM, visit www.dexcom.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230124005399/en/
DexCom, Inc.: Sean Christensen Vice President – Finance
and Investor Relations investor-relations@dexcom.com (858)
200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024